4.4 Article

A MULTICENTER OPEN-LABEL EXPERIENCE ON THE RESPONSE OF PSORIASIS TO ADALIMUMAB AND EFFECT OF DOSE ESCALATION IN NON-RESPONDERS: THE APHRODITE PROJECT

Related references

Note: Only part of the references are listed.
Article Dermatology

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Alan Menter et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)

Article Dermatology

Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics

Marina Papoutsaki et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)